Hosenkoside A has shown potential in anti-inflammatory applications due to its ability to inhibit key inflammatory mediators such as nitric oxide and prostaglandin E2 in cellular models. It is studied for its bioactive properties, particularly in modulating immune responses and reducing oxidative stress. Research also suggests possible neuroprotective effects, making it a compound of interest in the development of therapies for neurodegenerative conditions. Its natural origin and structural complexity contribute to its use as a lead compound in drug discovery, especially in designing derivatives with enhanced biological activity and selectivity.